Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$1.5 - $3.41 $9,696 - $22,042
-6,464 Reduced 10.69%
54,000 $136,000
Q4 2023

Feb 14, 2024

SELL
$1.82 - $3.16 $51,307 - $89,083
-28,191 Reduced 31.8%
60,464 $145,000
Q3 2023

Nov 14, 2023

SELL
$3.17 - $7.91 $12,011 - $29,970
-3,789 Reduced 4.1%
88,655 $301,000
Q1 2023

May 15, 2023

SELL
$7.79 - $16.29 $674,247 - $1.41 Million
-86,553 Reduced 48.35%
92,444 $957,000
Q4 2022

Feb 14, 2023

BUY
$11.0 - $21.45 $330,473 - $644,422
30,043 Added 20.17%
178,997 $2.11 Million
Q3 2022

Nov 15, 2022

BUY
$20.09 - $35.8 $1 Million - $1.79 Million
50,008 Added 50.54%
148,954 $3.13 Million
Q2 2022

Aug 15, 2022

SELL
$27.42 - $43.63 $1.1 Million - $1.75 Million
-40,004 Reduced 28.79%
98,946 $3.07 Million
Q1 2022

May 13, 2022

BUY
$36.48 - $52.22 $1.48 Million - $2.12 Million
40,578 Added 41.25%
138,950 $5.71 Million
Q4 2021

Feb 14, 2022

SELL
$33.11 - $55.01 $1.93 Million - $3.2 Million
-58,183 Reduced 37.16%
98,372 $4.28 Million
Q3 2021

Nov 10, 2021

BUY
$50.07 - $66.05 $924,542 - $1.22 Million
18,465 Added 13.37%
156,555 $7.84 Million
Q2 2021

Jul 30, 2021

SELL
$56.61 - $80.46 $201,531 - $286,437
-3,560 Reduced 2.51%
138,090 $8.7 Million
Q1 2021

May 06, 2021

BUY
$86.23 - $125.19 $36,561 - $53,080
424 Added 0.3%
141,650 $13.2 Million
Q4 2020

Feb 08, 2021

SELL
$79.17 - $111.47 $100,070 - $140,898
-1,264 Reduced 0.89%
141,226 $12.7 Million
Q3 2020

Nov 12, 2020

BUY
$81.91 - $134.94 $1.69 Million - $2.78 Million
20,597 Added 16.9%
142,490 $14.7 Million
Q2 2020

Aug 13, 2020

BUY
$54.33 - $89.52 $537,323 - $885,352
9,890 Added 8.83%
121,893 $9.64 Million
Q1 2020

May 14, 2020

SELL
$49.34 - $68.76 $321,598 - $448,177
-6,518 Reduced 5.5%
112,003 $6.48 Million
Q4 2019

Feb 18, 2020

BUY
$51.21 - $59.06 $10,242 - $11,812
200 Added 0.17%
118,521 $6.39 Million
Q3 2019

Nov 14, 2019

SELL
$40.6 - $57.2 $525,770 - $740,740
-12,950 Reduced 9.87%
118,321 $6.19 Million
Q2 2019

Aug 14, 2019

BUY
$39.92 - $53.86 $734,528 - $991,024
18,400 Added 16.3%
131,271 $6.34 Million
Q1 2019

May 14, 2019

BUY
$48.23 - $66.16 $209,269 - $287,068
4,339 Added 4.0%
112,871 $5.7 Million
Q4 2018

Feb 13, 2019

SELL
$55.63 - $73.24 $1.02 Million - $1.34 Million
-18,248 Reduced 14.39%
108,532 $6.43 Million
Q3 2018

Nov 08, 2018

BUY
$52.05 - $66.51 $1.14 Million - $1.46 Million
21,908 Added 20.89%
126,780 $8.35 Million
Q2 2018

Aug 13, 2018

BUY
$48.33 - $55.64 $840,942 - $968,136
17,400 Added 19.89%
104,872 $5.3 Million
Q4 2017

Feb 13, 2018

SELL
$37.77 - $47.75 $185,073 - $233,975
-4,900 Reduced 5.3%
87,472 $4.07 Million
Q3 2017

Nov 13, 2017

BUY
$34.14 - $40.45 $3.15 Million - $3.74 Million
92,372
92,372 $3.74 Million

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $420M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.